Delcath Systems, Inc. (DCTH) Stock Grade

About Delcath Systems, Inc.'s fundamentals

Delcath Systems is a medical device company with a market capitalization of $361.8 million that is experiencing rapid revenue growth of 129.1% year-over-year, indicating strong commercial traction. However, the company trades at a P/E ratio of 134.0, reflecting significant market expectations for future profitability, while currently maintaining only a modest 3.2% net margin. Return on equity stands at just 2.4%, suggesting limited efficiency in generating returns from shareholder capital at present. The company does not pay a dividend, with all resources directed toward operations and growth.